Table 2.

Primary sites of hepatic metastases and its distribution in each group.

Patient groups	Site of primary lesions	Number of cases	Constituent ratio in each group (%)
TP, 95, (76.61%)	Stomach	16	16.84
	Lung	13	13.68
	Colon	15	15.79
	Small intestine	3	3.16
	Female reproductive system	10	10.53
	Rectum	8	8.42
	Pancreas	3	3.16
	Breast	5	5.26
	Esophagus	10	10.52
	Laryngopharynx	2	2.10
	Pleura	2	2.10
	Other	6	6.32
FP, 9, (7.26%)	Lung	3	33.33
	Colon	2	22.22
	Stomach	1	11.11
	Esophagus	1	11.11
	Small intestine	1	11.11
	Common bile duct	1	11.11
TN, 8, (6.45%)	None
FN, 12, (9.68%)	Stomach	2	16.67
	Kidney	2	16.67
	Pancreas	2	16.67
	Rectum	1	8.33
	Ureter	1	8.33
	Lung	1	8.33
	Peritoneum	1	8.33
	Vastus intermedius	1	8.33
	Prostate	1	8.33

FN = false negative, FP = false positive, TN = true negative, TP = true positive.